Chitosan Phonophresis on Cervical IN Smartphone Addicted Users

NCT ID: NCT06491992

Last Updated: 2024-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-01

Study Completion Date

2024-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A phonophoresis-based drug delivery system is a synchronous approach to improve local drug penetration in neuromuscular diseases associated with neuronal damage, excruciating pain, and local inflammation. Chitosan, a semi-synthetic material, is obtained by partial deacetylation of chitin amines, resulting in copolymers of N-acetylglucosamine and N-glucosamine. Its use has been explored in various biomaterial and medical applications. Chitosan has emerged as a cost-effective, biocompatible, and biodegradable material with many desirable biological properties, improvement of homeostasis and antiviral potential. Chitosan was found to suppress pro-inflammatory cytokines and decreased peripheral nerve edema, the polycationic nature of chitosan allows it to absorb protons, which reduces inflammation and provides an analgesic effect.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patients will randomly be divided into two equal groups; the control group which will receive the selected exercise program and the study group will receive the same exercise training program in addition to Chitosan Phonophresis, three times per week for four weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group

Chitosan Phonophresis intervention

Group Type EXPERIMENTAL

Chitosan Phonophresis

Intervention Type DRUG

Chitosan Phonophresis, three times per week for four weeks.

selected physical therapy exercise

Intervention Type OTHER

selected neck exercise and electrotherapy on cervical region

control group

the selected exercise program

Group Type EXPERIMENTAL

selected physical therapy exercise

Intervention Type OTHER

selected neck exercise and electrotherapy on cervical region

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chitosan Phonophresis

Chitosan Phonophresis, three times per week for four weeks.

Intervention Type DRUG

selected physical therapy exercise

selected neck exercise and electrotherapy on cervical region

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Their age will be ranged from 16-18 years
* body mass index will be 26.58 kg/m2.
* used a smart phone for more than 1 year for at least 2 hours per day
* complaining of neck pain after using a smart phone, addiction to smart phone in accordance with the smart phone addiction scale (SAS)

Exclusion Criteria

* any previous head and neck injuries or surgeries
* any congenital abnormalities or symptomatic deformity in either the cervical or the lumbar spine
* any uncorrected visual or auditory problems, dizziness, vertigo and headache
* any systematic diseases, any addiction to alcohol, any additive drugs and sedatives within 48 hours previous to tests
* body mass index of subjects over25 kg/m2.
Minimum Eligible Age

16 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

October 6 University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lama Saad El-Din Mahmoud

Lama Saad El-Din Mahmoud

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lama S Mahmoud

Al Jīzah, Select State, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lama Saad El-Din ED Mahmoud

Role: CONTACT

01157592636

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lama S Mahmoud

Role: primary

01157592636

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

O6U.PT.REC/024/002003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.